Michael C. Levin

Michael C. Levin, M.D. is the Saskatchewan Multiple Sclerosis Clinical Research Chair and Professor of Neurology and Anatomy, Physiology and Pharmacology and at the University of Saskatchewan in Saskatoon, Saskatchewan.

Dr. Levin received his Bachelors’ of Science degree in chemistry with special honors at the George Washington University in Washington D.C. It was at ‘GW’ where Dr. Levin began his research career studying the role of thymic peptides in nervous system infections. He completed his medical degree at the Pennsylvania State University. To acquire greater depth into neuroscience research, Dr. Levin took a year sabbatical from medical school to study central nervous system control of hypertension at The Salk Institute under the direction of Drs. Max Cowan and Paul Sawchenko. Understanding that clinical expertise was equally important as experience at the bench, Dr. Levin completed his residency training in neurology at The New York Hospital/Cornell Medical Center – Memorial Sloan Kettering Cancer Center in New York City. Drs. Fred Plum and Jerry Posner mentored him during his residency including while he was chief neurology resident during his final year of training. In order to apply both his basic science and clinical skills to a neurological disease, Dr. Levin spent four years working in the Neuroimmunology Branch – the translational research group specifically focused on MS - at the National Institutes of Health in Bethesda, Maryland.

Subsequently, Dr. Levin was recruited by the University of Tennessee Health Science Center and Veterans Affairs Medical Center in Memphis, Tennessee, to create both a clinical and research program in MS. Being fortunate to be mentored by some of the greatest leaders in neurology and neuroscience, afforded Dr. Levin the foundational skills required to develop a vision for translational research in MS. Clinically, Dr. Levin followed more than 500 MS patients, his work has been recognized by the National Multiple Sclerosis Society for the first ever clinical trial in MS in Memphis, has been elected into the Best Doctors in America database from 2005-18.